Matthias Klinger

Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

Hermann Einsele, Carsten Reinhardt, Thomas Burmeister, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Impact of Various Reactive Oxygen Species on the Formation of Neutrophil Extracellular Traps

Werner Solbach, S. Möller, M. Behnen, 2012, Mediators of inflammation.

Jellyfish collagen scaffolds for cartilage tissue engineering.

Anja Lode, Michael Gelinsky, Sascha Heinemann, 2014, Acta biomaterialia.

Immobilized Immune Complexes Induce Neutrophil Extracellular Trap Release by Human Neutrophil Granulocytes via FcγRIIIB and Mac-1

Werner Solbach, S. Möller, M. Behnen, 2014, The Journal of Immunology.

Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab.

Andreas Wolf, Dirk Nagorsen, Monika Brüggemann, 2012, Blood.

Jellyfish collagen matrices conserve the chondrogenic phenotype in two‐ and three‐dimensional collagen matrices

H. Notbohm, Judith Sewing, Matthias Klinger, 2017, Journal of tissue engineering and regenerative medicine.